Re: BPH story of a PCa patient
- From: ralphv_in_az@xxxxxxxxx
- Date: 11 Jun 2006 07:39:41 -0700
Hi Ron,
It would depend if the action of Avodart included activity against
prostate cancer tissue. They are starting to recognize the value of
5-AR inhibitors in the treatment of PCa. Not widely accepted as things
go in the world of PCa, but nevertheless more used than ever before.
In this case, where BPH and PCa are known to be present, a PSA
reduction of almost 50% seems to be significant. At the very least it
tells us that there is androgen dependence. That is in my estimation
reassuring to the patient who is conservativly managing his disease.
Best regards,
RalphV
ron wrote:
Leonard Evens wrote...snip...
It is interesting that your PSA has dropped significantly. Presumably
your previous PSA level resulted primarily from your BPH rather than the
cancer, and the Avodart apparently reduced the BPH.
Not sure I'd agree that the PSA dropped significantly. Avodart
(dutasteride) will cut PSA's roughly in half. Doubling the current
value of 2.6 takes us to 5.2 which, given test variation, is pretty
close to the 11/00 value of 5.7...ron.
.
- Follow-Ups:
- Re: BPH story of a PCa patient
- From: ron
- Re: BPH story of a PCa patient
- References:
- BPH story of a PCa patient
- From: Lawrence J. Bookbinder
- Re: BPH story of a PCa patient
- From: Leonard Evens
- Re: BPH story of a PCa patient
- From: ron
- BPH story of a PCa patient
- Prev by Date: PSA Questions
- Next by Date: Re: BPH story of a PCa patient
- Previous by thread: Re: BPH story of a PCa patient
- Next by thread: Re: BPH story of a PCa patient
- Index(es):
Relevant Pages
|
